Nanobac Historical Cash Flow
| NNBP Stock | USD 0.0001 0.00 0.00% |
Analysis of Nanobac Pharmaceuticals cash flow over time is an excellent tool to project Nanobac Pharmaceuticals future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Change To Inventory of 67.7 K or Total Cashflows From Investing Activities of 56.8 K as it is a great indicator of Nanobac Pharmaceuticals ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Nanobac Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Nanobac Pharmaceuticals is a good buy for the upcoming year.
Nanobac |
About Nanobac Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Nanobac balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Nanobac's non-liquid assets can be easily converted into cash.
Nanobac Pharmaceuticals Cash Flow Chart
Add Fundamental
Change To Inventory
The increase or decrease in the amount of inventory a company has over a certain period.Net Borrowings
The difference between the amount of new debt a company has taken on and the amount of debt it has paid off during a given period.Most accounts from Nanobac Pharmaceuticals' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Nanobac Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nanobac Pharmaceuticals Incorporated. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. At this time, Nanobac Pharmaceuticals' Change To Liabilities is relatively stable compared to the past year. As of 12/02/2024, Change To Inventory is likely to grow to about 67.7 K, though Change To Account Receivables is likely to grow to (992.66).
| 2010 | 2011 | 2023 | 2024 (projected) | Change To Inventory | 67K | 56.0K | 64.5K | 67.7K | Change To Liabilities | 346K | 669.7K | 602.7K | 632.9K |
Nanobac Pharmaceuticals cash flow statement Correlations
Click cells to compare fundamentals
Nanobac Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Additional Tools for Nanobac Stock Analysis
When running Nanobac Pharmaceuticals' price analysis, check to measure Nanobac Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nanobac Pharmaceuticals is operating at the current time. Most of Nanobac Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Nanobac Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nanobac Pharmaceuticals' price. Additionally, you may evaluate how the addition of Nanobac Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.